Title

Utility of B-RAF DNA mutation in diagnosis and treatment of cancer

Document Type

Patent

File Date

5-11-2012

Abstract

The present invention discloses a method of detecting a wild-type or mutant B-RAF gene in a body fluid sample from a subject. Also disclosed are methods of using B-RAF as a biomarker for detecting cancer, predicting the outcome of cancer, and monitoring the treatment of cancer or the status of cancer. Furthermore, the invention discloses methods and compositions for detecting a mutant gene with a peptide nucleic acid clamp capable of hybridizing to a wild-type gene and a locked nucleic acid probe capable of hybridizing to a mutant of the gene.

Clinical Institute

Cancer

Department

Oncology

Location

United States

Comments

Patent Number: 9,567,640

Assignee

JOHN WAYNE CANCER INSTITUTE (Santa Monica, CA)

Family ID

39721826

Serial Number

13/470,169

Tech ID

07-JWCI-052

Share

COinS